Published in Am J Epidemiol on February 15, 2003
Invited commentary: condom effectiveness-will prostate-specific antigen shed new light on this perplexing problem? Am J Epidemiol (2003) 2.45
Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions. Sex Transm Infect (2005) 1.28
Prostate-specific antigen as a biomarker of condom failure: comparison of three laboratory assays and self-reported condom use problems in a randomized trial of female condom performance. Contraception (2012) 0.87
Objective non-intrusive markers of sperm production and sexual activity. Asian J Androl (2012) 0.81
The use of biomarkers of semen exposure in sexual and reproductive health studies. J Womens Health (Larchmt) (2014) 0.77
Who are the preferential targets for intervention programs related to the female condom among sex workers in southern China? AIDS Educ Prev (2013) 0.75
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet (2008) 19.65
Fertility treatments and multiple births in the United States. N Engl J Med (2013) 3.45
Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst (2003) 2.81
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat Med (2011) 2.71
Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe. Am J Epidemiol (2009) 2.57
Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol (2004) 2.49
Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand. J Acquir Immune Defic Syndr (2002) 2.48
Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi. Contemp Clin Trials (2008) 2.35
A patient-controlled journal for an electronic medical record: issues and challenges. Stud Health Technol Inform (2004) 2.35
Perinatal outcome among singleton infants conceived through assisted reproductive technology in the United States. Obstet Gynecol (2004) 2.34
Male circumcision and risk of HIV infection among heterosexual African American men attending Baltimore sexually transmitted disease clinics. J Infect Dis (2009) 2.22
Efficacy of the female condom as a barrier to semen during intercourse. Am J Epidemiol (2003) 2.20
Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis (2006) 2.17
The acceptability of the female and male condom: a randomized crossover trial. Perspect Sex Reprod Health (2004) 1.90
Maternal mortality among Afghan refugees in Pakistan, 1999-2000. Lancet (2002) 1.74
Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine. J Clin Invest (2011) 1.73
The use of nonhuman primate models in HIV vaccine development. PLoS Med (2008) 1.73
Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.71
Assisted reproductive technology surveillance--United States, 2006. MMWR Surveill Summ (2009) 1.70
Trends in multiple births conceived using assisted reproductive technology, United States, 1997-2000. Pediatrics (2003) 1.69
Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA. Contraception (2013) 1.68
A semiparametric approach to estimate rapid lung function decline in cystic fibrosis. Ann Epidemiol (2013) 1.68
Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine. Curr Opin HIV AIDS (2010) 1.63
Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis (2003) 1.57
Performance evaluation of blood glucose monitoring devices. Diabetes Technol Ther (2003) 1.56
The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol (2009) 1.56
Assisted reproductive technology surveillance--United States, 2005. MMWR Surveill Summ (2008) 1.51
Safe conception for HIV-discordant couples: insemination with processed semen from the HIV-infected partner. Am J Obstet Gynecol (2013) 1.45
Seroprevalence of human herpesvirus 8 infection in Northern Thailand. Clin Infect Dis (2004) 1.45
Involving communities in the design of clinical trial protocols: the BAN Study in Lilongwe, Malawi. Contemp Clin Trials (2006) 1.45
Assisted reproductive technology surveillance - United States, 2004. MMWR Surveill Summ (2007) 1.43
Infertility services reported by men in the United States: national survey data. Fertil Steril (2008) 1.42
Accuracy of assisted reproductive technology information on the Massachusetts birth certificate, 1997-2000. Fertil Steril (2009) 1.38
Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. J Low Genit Tract Dis (2007) 1.37
Assisted reproductive technology surveillance--United States, 2003. MMWR Surveill Summ (2006) 1.35
Probabilistic linkage of assisted reproductive technology information with vital records, Massachusetts 1997-2000. Matern Child Health J (2012) 1.34
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol (2010) 1.31
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer (2006) 1.28
Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.28
Strategies for developing biostatistics resources in an academic health center. Acad Med (2013) 1.27
Randomized controlled trial of health maintenance reminders provided directly to patients through an electronic PHR. J Gen Intern Med (2011) 1.27
Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads. J Acquir Immune Defic Syndr (2008) 1.26
Perinatal outcomes of twin births conceived using assisted reproduction technology: a population-based study. Hum Reprod (2008) 1.26
Biological markers of sexual activity: tools for improving measurement in HIV/sexually transmitted infection prevention research. Sex Transm Dis (2013) 1.24
Trends and correlates of good perinatal outcomes in assisted reproductive technology. Obstet Gynecol (2012) 1.23
Breast milk and HIV-1: vector of transmission or vehicle of protection? Lancet Infect Dis (2003) 1.20
Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial. Am J Epidemiol (2007) 1.20
Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women. Am J Epidemiol (2006) 1.20
A population-based study of maternal and perinatal outcomes associated with assisted reproductive technology in Massachusetts. Matern Child Health J (2007) 1.20
Survival of blood donors and their spouses with HIV-1 subtype E (CRF01 A_E) infection in northern Thailand, 1992-2007. AIDS (2007) 1.19
Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res (2004) 1.18
Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. Am J Epidemiol (2005) 1.16
Good performance of rapid prostate-specific antigen test for detection of semen exposure in women: implications for qualitative research. Sex Transm Dis (2009) 1.16
Effectiveness of female and male condoms in preventing exposure to semen during vaginal intercourse: a randomized trial. Contraception (2005) 1.16
Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic. Sex Transm Dis (2008) 1.13
Self-reported mechanical problems during condom use and semen exposure. Comparison of two randomized trials in the United States of America and Brazil. Sex Transm Dis (2007) 1.13
Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol (2002) 1.12
Is cryopreservation of embryos a legitimate surrogate marker of embryo quality in studies of assisted reproductive technology conducted using national databases? Fertil Steril (2012) 1.10
Prostate-specific antigen in vaginal fluid after exposure to known amounts of semen and after condom use: comparison of self-collected and nurse-collected samples. Hum Reprod (2008) 1.10
Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity. PLoS One (2010) 1.09
Accuracy of assisted reproductive technology information on birth certificates: Florida and Massachusetts, 2004-06. Paediatr Perinat Epidemiol (2014) 1.07
Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi. AIDS Educ Prev (2009) 1.07
Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus. Obstet Gynecol (2006) 1.06
Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort. J Acquir Immune Defic Syndr (2005) 1.06
Broad human immunodeficiency virus (HIV)-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner. J Infect Dis (2003) 1.05
Singleton preterm birth: risk factors and association with assisted reproductive technology. Matern Child Health J (2012) 1.04
A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia. Cancer (2010) 1.01
Lower red blood cell folate enhances the HPV-16-associated risk of cervical intraepithelial neoplasia. Nutrition (2007) 1.00
Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles. PLoS Pathog (2011) 1.00
Bacterial vaginosis, gonorrhea, and chlamydial infection among women attending a sexually transmitted disease clinic: a longitudinal analysis of possible causal links. Ann Epidemiol (2011) 1.00
Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination. J Clin Invest (2002) 0.99
Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and sufficient vitamin B12 in the post-folic acid fortification era. Cancer Prev Res (Phila) (2009) 0.99
Characteristics of users of intrauterine devices and other reversible contraceptive methods in the United States. Fertil Steril (2011) 0.98
Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1. Clin Infect Dis (2002) 0.97
T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected women. J Acquir Immune Defic Syndr (2007) 0.97
Large refractive index change in silicone-based and non-silicone-based hydrogel polymers induced by femtosecond laser micro-machining. Opt Express (2006) 0.97
Anamnestic immune response to dengue and decreased severity of yellow Fever. J Glob Infect Dis (2009) 0.96
Predictors of unprotected sex among female sex workers in Madagascar: comparing semen biomarkers and self-reported data. AIDS Behav (2010) 0.95
Contraceptive sterilization among married adults: national data on who chooses vasectomy and tubal sterilization. Contraception (2011) 0.94
Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control study. AIDS (2011) 0.94
The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis (2002) 0.93
Reasons for testing and clinical and demographic profile of adolescents with non-perinatally acquired HIV infection. Pediatrics (2006) 0.93
Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults. AIDS Res Hum Retroviruses (2010) 0.93
Empowering patients to improve the quality of their care: design and implementation of a shared health maintenance module in a US integrated healthcare delivery network. Stud Health Technol Inform (2007) 0.92
Vaginal flora morphotypic profiles and assessment of bacterial vaginosis in women at risk for HIV infection. Infect Dis Obstet Gynecol (2005) 0.92
Effect of topical vaginal products on the detection of prostate-specific antigen, a biomarker of semen exposure, using ABAcards. Contraception (2012) 0.92
Accuracy of Papanicolaou test among HIV-infected women. Clin Infect Dis (2006) 0.92
Viral load and CD4 count dynamics after HIV-1 seroconversion in homosexual and bisexual men in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr (2006) 0.92
Acceptability of five nonoxynol-9 spermicides. Contraception (2005) 0.91